The effect of FOXA2rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals

BMC Medical Genetics

Research Article

Annelli Sandbæk¹  Torsten Lauritzen¹  Torben Jørgensen²  Daniel R Witte³  Thomas Sparsø⁴  Mette Hollensted⁴  Karina Banasik⁴  Ehm Andersson⁴  Oluf Pedersen⁵  Torben Hansen⁶ 

[1] Department of General Practice, University of Aarhus, Aarhus, Denmark;Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark;Steno Diabetes Center, Gentofte, Denmark;The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;Faculty of Health Sciences, University of Aarhus, Aarhus, Denmark;Hagedorn Research Institute, Gentofte, Denmark;The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;Hagedorn Research Institute, Gentofte, Denmark;Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark;

关键词: Fasting Plasma Glucose;    Oral Glucose Tolerance Test;    Fasting Plasma Glucose Level;    FOXA Gene;    General Danish Population;   

DOI  :  10.1186/1471-2350-13-10

 received in 2011-07-28, accepted in 2012-02-12,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundVariations within the FOXA family have been studied for a putative contribution to the risk of type 2 diabetes (T2D), and recently the minor T-allele of FOXA2 rs1209523 was reported to associate with decreased fasting plasma glucose levels in a study using a weighted false discovery rate control procedure to enhance the statistical power of genome wide association studies in detecting associations between low-frequency variants and a given trait.Thus, the primary aim of this study was to investigate whether the minor T-allele of rs1205923 in FOXA2 associated with 1) decreased fasting plasma glucose and 2) a lower risk of developing T2D. Secondly, we investigated whether rs1205923 in FOXA2 associated with other glucose-related phenotypes.MethodsThe variant was genotyped in Danish individuals from four different study populations using KASPar® PCR SNP genotyping system. We examined for associations of the FOXA2 genotype with fasting plasma glucose and estimates of insulin release and insulin sensitivity following an oral glucose tolerance test in 6,162 Danish individuals from the population-based Inter99 study while association with T2D risk was assessed in 10,196 Danish individuals including four different study populations.ResultsThe FOXA2 rs1209523 was not associated with fasting plasma glucose (effect size (β) = -0.03 mmol/l (95%CI: -0.07; 0.01), p = 0.2) in glucose-tolerant individuals from the general Danish population. Furthermore, when employing a case-control setting the variant showed no association with T2D (odds ratio (OR) = 0.82 (95%CI: 0.62-1.07), p = 0.1) among Danish individuals. However, when we performed the analysis in a subset of 6,022 non-obese individuals (BMI < 30 kg/m2) an association with T2D was observed (OR = 0.68 (95%CI: 0.49-0.94), p = 0.02). Also, several indices of insulin release and β-cell function were associated with the minor T-allele of FOXA2 rs1209523 in non-obese individuals.ConclusionsWe failed to replicate association of the minor T-allele of FOXA2 rs1209523 with fasting plasma glucose in a population based sample of glucose tolerant individuals. More extensive studies are needed in order to fully elucidate the potential role of FOXA2 in glucose homeostasis.

【 授权许可】

CC BY   
© Banasik et al; licensee BioMed Central Ltd. 2012